DexCom (XSWX:DXCM) 50-Day SMA: CHF53.19 (As of Jun. 26, 2026)


XSWX:DXCM DexCom Inc XSWX:DXCM
90 GF Score
Price CHF56.54
GF Value CHF85.31
! 3 Warning Signs
View Full Analysis

What is DexCom 50-Day SMA?

DexCom XSWX:DXCM 90 50-Day SMA is CHF53.19 as of Jun. 26, 2026. GuruFocus rates XSWX:DXCM with a GF Score™ of 90/100 and a GF Value™ of CHF85.31. The stock has 3 warning signs investors should review.

Moving averages are one of the core indicators in technical analysis. A Simple Moving Average (SMA) is simply the arithmetic average of stock price over a period. It is calculated by adding a selected range of prices, usually closing prices, and then dividing that figure by the number of time periods in that range.

The 50-Day SMA calculates the average price over 50 days. And the 20-Day SMA and 200-Day SMA calculates the average price over 20 days and 200 days separately.

As of today (2026-06-26), DexCom's 50-Day SMA is CHF53.19. It's 20-Day SMA is CHF58.45 and 200-Day SMA is CHFN/A.


DexCom  (XSWX:DXCM) 50-Day SMA Explanation

Simple Moving Average (SMA) is the arithmetic average of stock price over a period. The 20-Day SMA calculates the average price over 20 days. And the 50-Day SMA and 200-Day SMA calculates the average price over 50 days and 200 days separately. SMAs are often used to determine the price trend direction. A 200-Day SMA is usually a proxy for the long-term trend, while shorter periods indicate short-term trend.

SMA are commonly compared with stock price or different period SMAs to indicate a trading signal. Generally speaking, if the price goes above the SMA, or a short-term SMA crosses above a long-term SMA, an uptrend is expected, investors may want to go long or cover short. Conversely, if the price goes below the SMA, or the short-term SMA crosses below a long-term SMA, a downtrend is expected, investors may want to go short or exit long.

Two popular trading patterns that use SMA include the death cross and a golden cross. A death cross occurs when the 50-day SMA crosses below the 200-day SMA. This is considered a bearish signal, that further losses are in store. The golden cross is a bullish signal which occurs when a short-term SMA crosses above a long-term SMA.


DexCom 50-Day SMA Related Terms


XSWX:DXCM vs GEHC, STE, ZBH: 50-Day SMA Comparison

For the Medical Devices subindustry, DexCom's 50-Day SMA, along with its competitors' market caps and 50-Day SMA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DexCom 50-Day SMA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DexCom's 50-Day SMA distribution charts can be found below:

* The bar in red indicates where DexCom's 50-Day SMA falls into.


XSWX:DXCM
90GF Score
DexCom Inc XSWX:DXCM
50-Day SMA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexCom  (XSWX:DXCM) 50-Day SMA Calculation

The formula for calculating SMA is:

SMA=( P1 + P2 + ... + Pn ) / n

where:
Pn is the price of the stock at period n.
n is the total number of periods.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 50-Day SMA →
What does a 50-Day SMA of CHF53.19 mean?
DexCom (XSWX:DXCM) has a 50-Day SMA of CHF53.19 as of Jun. 26, 2026. Simple Moving Average (SMA) is the arithmetic average of stock price over a period. View historical data on DexCom and its competitors.
Is DexCom's 50-Day SMA too high?
DexCom's current 50-Day SMA is CHF53.19. Overall, DexCom has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does DexCom's 50-Day SMA compare to GEHC and STE?
DexCom's 50-Day SMA of CHF53.19 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 50-Day SMA for a Medical Devices & Instruments company?
A good 50-Day SMA depends on the Medical Devices & Instruments industry context. However, 50-Day SMA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 50-Day SMA mean?
A high 50-Day SMA can signal that a stock is expensive relative to its fundamentals. Simple Moving Average (SMA) is the arithmetic average of stock price over a period. View historical data on DexCom and its competitors. DexCom's current 50-Day SMA is CHF53.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexCom stock overvalued right now?
DexCom (XSWX:DXCM) has a current 50-Day SMA of CHF53.19. The stock's GF Value™ is CHF85.31, compared to a current price of CHF56.54 — trading 33.7% below its estimated fair value. The current 50-Day SMA is CHF53.19. DexCom's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 50-Day SMA calculated?
50-Day SMA is calculated from a company's financial statements. For DexCom (XSWX:DXCM), the current 50-Day SMA is CHF53.19 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DexCom (XSWX:DXCM) Overvalued in 2026?

Based on GuruFocus' analysis, DexCom stock appears to be undervalued. The current stock price of CHF56.54 is trading 33.7% below its estimated GF Value™ of CHF85.31.

Key valuation signals for XSWX:DXCM:

  • 50-Day SMA: CHF53.19
  • GF Value™: CHF85.31 vs. price of CHF56.54 (33.7% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the XSWX:DXCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DexCom Business Description

Address 6340 Sequence Drive, San Diego, CA, USA, 92121
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
90GF Score

Get the complete analysis for XSWX:DXCM

50-Day SMA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF56.54
Price
CHF85.31
GF Value